[The microcirculatory function in the chronic HBs-antigen carrier state]

Vrachebnoe Delo
|November 1, 1990
PubMed

Insights

Chronic carriers of Hepatitis B surface antigen (HBsAg) often have liver damage and microcirculation issues. Early detection of circulatory problems can improve treatment and predict outcomes for HBsAg carriers.

Area of Science:

  • Hepatology
  • Virology
  • Internal Medicine

Background:

  • Chronic carrier state of Hepatitis B surface antigen (HBsAg) is a widespread issue in healthy individuals.
  • Prolonged Hepatitis B virus (HBV) persistence can lead to liver damage and microcirculatory disorders.

Purpose of the Study:

  • To investigate the clinical and etiological significance of microcirculatory disorders in HBsAg carriers.
  • To establish the role of early diagnosis of circulatory issues in managing HBsAg carriers.

Main Methods:

  • Clinical and biochemical examinations of HBsAg carriers.
  • Ultrasonic assessment of liver involvement.
  • Evaluation of microcirculation disorders.

Main Results:

  • Most HBsAg carriers exhibit moderate clinico-biochemical and ultrasonic signs of chronic liver disease.
  • Disorders of microcirculation are commonly observed in individuals with persistent HBV infection.
  • Early diagnosis of generalized terminal blood circulation disorders is feasible in HBsAg carriers.

Conclusions:

  • Microcirculatory disorders are a significant complication of chronic HBsAg carrier state.
  • Early detection of these circulatory issues aids in developing pathogenetically substantiated treatment.
  • Prognostication of unfavorable outcomes in the preclinical phase of chronic HBsAg carrier state can be improved.